Today starts classes in San Jacinto College's new center. Photo via sanjac.edu

San Jacinto College is gearing up to open the Center for Petrochemical, Energy, and Technology at its main campus in Pasadena — a $60 million project designed to bolster the Houston area's petrochemical workforce.

On August 21, the community college hosted media tours of the Center for Petrochemical, Energy, and Technology (CPET). The center will welcome more than 2,800 students August 26 and host a grand opening September 18. The college broke ground on the 151,000-square-foot center in September 2017.

At CPET, future and current petrochemical workers will learn about process operations, troubleshooting, nondestructive testing, instrumentation, and myriad other aspects of the industry. In all, CPET will offer 75 courses. The center's highlights include an 8,000-square-foot glycol distillation unit, 35 labs, and 19 classrooms. San Jacinto College bills the center as the largest petrochemical training site in the Gulf Coast region.

"Four years ago, a team came together from San Jacinto College and the East Harris County Manufacturers Association to put together a long-term plan for workforce development," says Jim Griffin, associate vice chancellor at San Jacinto College and senior vice president of petrochemical, energy, and technology. "The Center for Petrochemical, Energy, and Technology was part of that plan and is now a reality."

Griffin says the curriculum, classrooms, and labs were "designed and influenced" by the petrochemical industry.

Among CPET's more than 20 partners are:

  • Emerson, which donated more than $1.3 million worth of services and equipment.
  • INEOS Olefins & Polymers USA, which contributed $250,000 in cash.
  • Dow Chemical, which donated $250,000 in cash.

All three of those employers — and many others in the region — depend on schools like San Jacinto College to contribute to the pool of highly trained workers in the petrochemical sector.

"We expect to see a higher-than-normal level of retirements over the next five plus years; rebuilding our workforce is critical at this time," Jeff Garry, Dow Chemical's operations director in the Houston area, said when his company's CPET donation was announced. "The need to train and adequately staff our assets will continue to be a pressing concern. As the labor market becomes more competitive for talent, we understand the importance to attract and retain highly skilled and educated workers."

With four campuses in Harris County, San Jacinto College promotes itself as a training hub for the country's largest petrochemical manufacturing complex, featuring 130 plants and employing about 100,000 people. CPET will serve as the centerpiece of that hub. Overall, the community college says it "plays a vital role in helping the region maintain its status as the 'Energy Capital of the World.'"

PetrochemWorks.com — a petrochemical career initiative whose backers include JPMorgan Chase & Co., the Council for Adult and Experiential Learning, and the East Harris County Manufacturing Association — says the local petrochemical industry will need 19,000 more skilled workers annually over the next three to five years.

"Chronic shortages of skilled labor are increasing costs and schedules and resulting in declining productivity, lower quality, more accidents, and missed objectives," according to Petrochemical Update, a news website.

Although robots are on the rise in many industries, Mark Mills, a senior fellow at the Manhattan Institute who's an energy and technology expert, believes that as petrochemical companies increasingly turn to automation, productivity will go up, ultimately creating more jobs — not fewer.

"In large part," Mills writes, "it's desperation, not an infatuation with tech or cost savings, that drives employers to deploy technologies that amplify the capabilities of the employees they have and can find. It is a common misconception to think that automation is always cheaper than using labor."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.